| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.382 | 3.146 | 0 | 7.967 | 14.641 | 6.072 | 7.277 | 4.056 | 0 | 0 |
| Total Income - EUR | 7.047 | 3.256 | 84 | 7.967 | 14.641 | 6.072 | 7.277 | 4.056 | 1.614 | 1.554 |
| Total Expenses - EUR | 6.450 | 3.921 | 463 | 5.656 | 4.903 | 484 | 409 | 1.768 | 1.549 | 446 |
| Gross Profit/Loss - EUR | 597 | -665 | -379 | 2.311 | 9.738 | 5.588 | 6.868 | 2.288 | 65 | 1.108 |
| Net Profit/Loss - EUR | 386 | -763 | -381 | 2.072 | 9.299 | 5.406 | 6.650 | 2.166 | -146 | 931 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dafimed Diagnosis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 | 29 |
| Current Assets | 27.461 | 8.285 | 714 | 4.861 | 10.882 | 16.093 | 22.351 | 24.544 | 25.480 | 26.413 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 7 |
| Receivables | 332 | 640 | 629 | 0 | 0 | 0 | 0 | 406 | 0 | 0 |
| Cash | 27.129 | 7.646 | 85 | 4.861 | 10.882 | 16.093 | 22.351 | 24.138 | 25.474 | 26.406 |
| Shareholders Funds | 26.486 | -200 | -578 | 1.505 | 10.775 | 15.977 | 22.272 | 24.508 | 24.287 | 995 |
| Social Capital | 45 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 975 | 8.485 | 1.292 | 3.356 | 106 | 116 | 79 | 36 | 1.222 | 25.447 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8129 - 8129" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dafimed Diagnosis Srl